1. 2012
  2. In vitro activity of candidate microbicides against cell-associated HIV. / Selhorst, P; Grupping, K; Bourlet, T; Delezay, O; Ariën, KK; Vanham, G.

    In: Antimicrobial Agents and Chemotherapy, Vol. 56, No. 2, 2012, p. 805-815.

    Research output: Contribution to journalA1: Web of Science-article

  3. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. / Singh, M.; Singh, P.; Gaudray, G.; Musumeci, L.; Thielen, C.; Vaira, D.; Vandergeeten, C.; Delacroix, L.; Van Gulck, E.; Vanham, G.; de Leval, L.; Rahmouni, S.; Moutschen, M.

    In: PLoS ONE, Vol. 7, No. 6, 2012, p. e38491.

    Research output: Contribution to journalA1: Web of Science-article

  4. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1. / Talledo, M; Lopez, G; Huyghe, JR; Verdonck, K; Gonzalez, E; Clark, D; Vanham, G; Gotuzzo, E; Van Camp, G; Van Laer, L.

    In: Journal of Medical Virology, Vol. 84, No. 2, 2012, p. 319-326.

    Research output: Contribution to journalA1: Web of Science-article

  5. Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine Visfatin/NAMPT. / Van den Bergh, R.; Morin, S.; Sass, H.J.; Grzesiek, S.; Vekemans, M.; Florence, E.; Than, H.T.T.; Imiru, R.G.; Heyndrickx, L.; Vanham, G.; De Baetselier, P.; Raes, G.

    In: PLoS ONE, Vol. 7, No. 4, 2012, p. e35074.

    Research output: Contribution to journalA1: Web of Science-article

  6. Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses. / Van Gulck, E.; Cools, N.; Atkinson, D.; Bracke, L.; Vereecken, Katleen; Vekemans, M.; Van Tendeloo, V.F.I.; Berneman, Z.N.; Vanham, G.

    In: Clinical and Developmental Immunology, Vol. 184979, 2012, p. 1-11.

    Research output: Contribution to journalA1: Web of Science-article

  7. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. / Van Gulck, E.; Vlieghe, E; Vekemans, M; Van Tendeloo, VF; Van de Velde, A; Smits, E; Anguille, S; Cools, N; Goossens, H; Mertens, L; De Haes, W; Wong, J; Florence, E; Vanham, G; Berneman, ZN.

    In: AIDS, Vol. 26, No. 4, 2012, p. F1-F12.

    Research output: Contribution to journalA1: Web of Science-article

  8. Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1? / Vanham, G.; Van Gulck, E.

    In: Retrovirology, Vol. 9, No. 72, 2012, p. 1-21.

    Research output: Contribution to journalA1: Web of Science-article

  9. Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents. / Venkatraj, M.; Ariën, K.K.; Heeres, J.; Joossens, J.; Messagie, J.; Michiels, J.; Van der Veken, P.; Vanham, G.; Lewi, P.J.; Augustyns, K.

    In: Bioorganic and Medicinal Chemistry Letters, Vol. 22, No. 23, 2012, p. 7174-7178.

    Research output: Contribution to journalA1: Web of Science-article

  10. 2011
  11. A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides. / Ariën, KK; Vanham, G; Gali, Y.

    In: Current Protocols in Cell Biology, Vol. 52, 2011, p. 26.13.1-26.13.17.

    Research output: Contribution to journalA2: International peer reviewed article (not A1-type)

Previous 12 3 4 5 6 7 8 9 ...20 Next

ID: 4718